| 000 | 01569 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513035705.0 | ||
| 264 | 0 | _c19951012 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1002/j.1552-4604.1995.tb05021.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Castro, S | |
| 245 | 0 | 0 |
_aNoninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosis. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cJun 1995 |
||
| 300 |
_a627-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aCartoni, D | |
| 700 | 1 | _aMillefiorini, E | |
| 700 | 1 | _aFunaro, S | |
| 700 | 1 | _aGasperini, C | |
| 700 | 1 | _aMorino, S | |
| 700 | 1 | _aTallarico, D | |
| 700 | 1 | _aBeni, S | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 35 _gno. 6 _gp. 627-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1995.tb05021.x _zAvailable from publisher's website |
| 999 |
_c7665156 _d7665156 |
||